Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren’s syndrome

Clinical Rheumatology

Volumn 34, Issue 2, 2015, Pages 247-253

  Zilahi, Erika ^a   Chen, Ji Qing ^a   Papp, Gábor ^a   Szántó, Antónia ^a   Zeher, Margit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Haplotypes; Sj gren s syndrome; SNP; Vitamin D receptor (VDR)

Indexed keywords

CALCITRIOL RECEPTOR;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; HUNGARY; MALE; MIDDLE AGED; SJOEGREN SYNDROME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HUNGARY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SJOGREN'S SYNDROME;

EID: 84939881601     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2639-6     Document Type: Article

References (29)

1. Zeher M (2009) Sjögren's syndrome. In: Zeher M, Szodoray P (eds) Sjögren’s syndrome and associated disorders. Transworld Research Network, Kerala
2. Jonsson R, Moen K, Vestrheim D, Szodoray P (2002) Current issues in Sjögren's syndrome. Oral Dis 83:130–140
3. Centola M, Frank MB, Bolstad AI et al (2006) Genome-scale assessment of molecular pathology in systemic autoimmune disease using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool. Scand J Immunol 64:236–242
4. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80:16895–16965
5. van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxivitamin D3: basic concept. J Steroid Biochem Mol Biol 97:93–101
6. Penna D, Adorini L (2000) Alpha, 25-dyhidroxivitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411
7. Cantorna MT (2010) Mechanism of vitamin D on the immune system. Proc Nutr Soc 69:286–289
8. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic consideration. Ann Rheum Dis 66:1137–1142
9. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143–156
10. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287
11. Morrison NA, Yeoman R, Kelly PJ, Eisman JA (1992) Contribution of trans-acting factor alleles to normal physiological variability:vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci 89:6665–6669
12. Faraco JH, Morrison NA, Baker A, Shine J, Frossard PM (1989) ApaI polymorphism at the human vitamin D receptor gene locus. Nucleic Acids Res 17:2150
13. Mishra DK, Wu Y, Sarkissyan H (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS 8:3
14. Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56:4108–4110
15. Vidal C, Grima C, Brincat M, Megally N, Xuereb-Anastasi A (2013) Associations of polymorphisms in the vitamin D receptor gene (BsmI and FokI) with bone mineral density in postmenopausal women in Malta. Osteoporos Int 14:923–928
16. Andraos C, Koorsen G, Knight JC, Bornman L (2011) Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and Tai polymorphism. Hum Immunol 72:262–268
17. Seo IY, Kang IH, Chae SC, Park SC, Lee YJ, Yang YS (2010) Vitamin D receptor gene AlwI, FokI, ApaI, and TaqI polymorphisms in patients with urinary stone. J Urol 75:923–927
18. Alagarasu K, Honap T, Mulay AP, Bachal RV, Shah PS, Cecilia D (2012) Association of vitamin D receptor gene polymorphisms with clinical outcomes. Hum Immunol 73:1194–1199
19. Feng M, Li H, Chen SF, Li WF, Zhang FB (2013) Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 43:318–326
20. Lee YH, Lee HS, Choi SJ, Ji JD, Song GG (2012) Association between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 39:3643–3651
21. Acikbas I, Sanli B, Tepeli E, Ergin S, Aktan S, Bagci H (2012) Vitamin D receptor gene polymorphisms and haplotypes (ApaI, BsmI, FokI, TaqI) in Turkish psoriasis patients. Med Sci Monit 18:661–666
22. Mostowska A, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP (2013) Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 40:803–810
23. Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgion A, Georgion I et al (2011) Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results BioMed 10:3
24. Rass P, Pákozdi A, Lakatos P, Zilahi E, Sipka S, Szegedi G et al (2006) Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 26:964–971
25. Monticielo OA, Teixeira Tde M, Chies JA, Brenol JC, Xavier RM (2012) Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol 31:1411–1421
26. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D (1997) The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12:1043–1048
27. Riggs BL, Nguyen TV, Melton LJ, Morrison NA, O'Fallon WM, Kelly PJ et al (1995) The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 10:991–995
28. Linkage Disequilibrium analysis. http://www.broad.mit.edu/mpg/haploview. [Online]
29. Szodoray P, Horváth IF, Papp G, Baráth S, Gyimesi E, Csathy L et al (2010) The immunoregulatory role of vitamins A, D and E in patients with primary Sjögren's syndrome. Rheumatology 49:211–217